Etsy’s 30% Slump in 2023 Could Be a Brilliant Entry Point for Returns in 2024 and Beyond
Here’s why Etsy’s 2023 stock dip could offer a window of opportunity for savvy investors in the new year.
Mindfully Curated
Here’s why Etsy’s 2023 stock dip could offer a window of opportunity for savvy investors in the new year.
ISRG earnings call for the period ending December 31, 2023.
A new database of weeds that can help scientists understand how traditional agricultural systems were managed throughout history, could also provide insights into how global trends like the climate crisis could affect the resilience of our modern day f…
A ‘fitness check’ of regulations in five countries meant to protect animals during transportation, has deemed that they all fall short of fully protecting animals during transport. Findings from this interdisciplinary work involving animal welfare scie…
The ability to walk one kilometer comfortably can help predict fracture risk, according to researchers. The findings suggest that simply asking a patient about walking limitation could allow clinicians to identify those in need of further bone health s…
Goerli blobs are here: Dencun went live on Goerli at 6:32 UTC on January 17, 2024. You can now use blobs there! Sepolia and Holesky will upgrade over the next two weeks. Dencun will activate on Sepolia at epoch 132608 (January 30th, 22:51 UTC), and on …
New research conducted by nuclear physicists is using a method that connects theories of gravitation to interactions among the smallest particles of matter. The result is insight into the strong force, a powerful mediator of particle interactions in th…
A new portable filtration system collects dirty water with a syringe and injects it into a hydrogel filter that weeds out nearly all tiny particles.
The blood-brain barrier, a protective cell layer guarding the brain, blocks foreign bodies but also hinders drug delivery, complicating treatment of neurological disorders.Scientists have now devised a method to deliver mRNA into the brain using lipid …
Metabolic dysfunction–associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis) is an inflammatory, liver-scarring disease that affects 1.5% to 6.5% of all U.S. adults. There are no approved pharmacological therapies for MASH…